Log in to save to my catalogue

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_10717544_2021_2008051

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

About this item

Full title

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

Publisher

England: Taylor & Francis

Journal title

Drug delivery, 2021-01, Vol.28 (1), p.2510-2524

Language

English

Formats

Publication information

Publisher

England: Taylor & Francis

More information

Scope and Contents

Contents

Poor aqueous solubility of eplerenone (EPL) is a major obstacle to achieve sufficient bioavailability after oral administration. In this study, we aimed to develop and evaluate eplerenone nanocrystals (EPL-NCs) for solubility and dissolution enhancement. D-optimal combined mixture process using Design-Expert software was employed to generate differ...

Alternative Titles

Full title

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1080_10717544_2021_2008051

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1080_10717544_2021_2008051

Other Identifiers

ISSN

1071-7544

E-ISSN

1521-0464

DOI

10.1080/10717544.2021.2008051

How to access this item